Blanca Osorio
Psychiatry · Natchitoches, LANPI 1962566166
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,453 and has fallen 90.7% since, to $135 in 2021.
Across 188 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$497
- Sunovion Pharmaceuticals Inc.$416
- Lundbeck LLC$359
- AbbVie$352
- Vanda Pharmaceuticals Inc.$287
- Alkermes, Inc.$268
- plus $766 from 8 others
What the payments were for
- Food & beverage$2,932100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $497 |
| Sunovion Pharmaceuticals Inc. | 26 | $416 |
| Lundbeck LLC | 26 | $359 |
| AbbVie(2 entities) | 32 | $352 |
| Vanda Pharmaceuticals Inc. | 14 | $287 |
| Alkermes, Inc. | 18 | $268 |
| Neurocrine Biosciences, Inc. | 6 | $221 |
| Teva Pharmaceuticals USA, Inc. | 9 | $138 |
| Johnson & Johnson | 7 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $92 |
| Shire North American Group Inc | 4 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $75 |
| Avanir Pharmaceuticals, Inc. | 2 | $29 |
| Indivior Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,945 in reported general payments places this provider in the 80th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 59 | $2,495 |
| Trazodone Hcl | 49 | $783 |
| Buspirone Hcl | 62 | $681 |
| Haloperidol | 14 | $524 |
| Hydroxyzine Hcl | 40 | $402 |
| Quetiapine Fumarate | 32 | $377 |
| Duloxetine Hcl | 35 | $351 |
| Benztropine Mesylate | 34 | $336 |
| Risperidone | 32 | $331 |
| Olanzapine | 27 | $292 |
| Mirtazapine | 15 | $228 |
| Bupropion XlBupropion Hcl | 25 | $182 |
| Paroxetine Hcl | 13 | $177 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $111 |
| Fluoxetine Hcl | 20 | $68 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Natchitoches
- Ovayoza AdeleyeNatchitoches$5K
- Patrick HayesLake Charles$837K
- Maria CruseThibodaux$522K
- Larry WarnerBaton Rouge$495K
- Gregory BrownShreveport$495K
- Arwen PodestaNew Orleans$466K
- Jasjit SinghShreveport$420K
- Roger BrownMandeville$216K
- Abdul KhanBaton Rouge$156K
- William ColombMandeville$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.